课题基金 / 基金详情

项目摘要

项目成果

Booki Min的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请方提供):免疫系统通过体内平衡调节的主动机制控制淋巴细胞的数量和活化状态。在转移到淋巴细胞减少的条件下,T细胞进行增殖以补偿淋巴细胞缺乏,而T细胞在转移到淋巴细胞充足的宿主后保持静止。这种增殖是如何诱导和调节的基本机制还没有很好地理解。我们先前已经证明了淋巴细胞减少条件下T细胞增殖的异质性:IL-7依赖性缓慢增殖和IL-7非依赖性快速增殖(称为“内源性增殖”)。此外,发现内源性增殖与向记忆表型细胞的分化密切相关,表明内源性增殖似乎涉及不同的机制。初步研究发现:1)进行内源性增殖的T细胞的初始积累主要在脾脏而不是在肠系膜淋巴结中发现:2)通过抗生素处理消耗肠道植物群对内源性增殖几乎没有影响:3)初始T细胞的内源性增殖主要由记忆T细胞的存在控制; 5)记忆性CD 4 T细胞抑制初始CD 4和CD 8 T细胞的内源性增殖,而记忆性CD 8 T细胞仅抑制初始CD 8 T细胞的内源性增殖; 6)记忆T细胞相互竞争,不仅要保持它们的池大小,而且要最大化库的复杂性。我们假设,内源性T细胞增殖,触发的自身抗原表达的DC产生了不同的记忆T细胞库。这些记忆细胞改变DC功能,进一步调节随后的幼稚T细胞增殖。为了检验这一假设,提出了三个具体目标。目的#1将确定DC是否是淋巴细胞减少宿主中诱导内源性增殖所必需的。目的#2将定义介导记忆T细胞抑制幼稚T细胞内源性增殖的细胞机制。目标#3将定义细胞凋亡对记忆细胞稳态的贡献。这些研究在临床上与建立避免淋巴细胞稳态失调的策略相关,淋巴细胞稳态失调通常见于自身免疫或治疗性免疫消融。公共卫生相关性:免疫系统进化出一种动态平衡控制机制,以确保其多样性和功能性。稳态失调被认为与多种疾病的发展有关,包括免疫缺陷、自身免疫和实体器官移植失败。目前的建议旨在研究潜在的细胞机制,其结果将有助于我们理解免疫机制,并促进治疗策略,以治疗由失调引起的疾病。
英文摘要
DESCRIPTION (provided by applicant): The immune system controls the numbers as well as the activation status of the lymphocytes by an active mechanism of homeostatic regulation. Following transfer into lymphopenic conditions, T cells undergo proliferation to compensate lymphocyte deficiency, while T cells remain quiescent after transfer into lymphocyte sufficient hosts. Underlying mechanisms of how such proliferation is induced and regulated are not well understood. We have previously demonstrated heterogeneity of T cell proliferation under lymphopenic conditions: IL-7-dependent slow proliferation and IL-7-independent fast proliferation (referred to as "endogenous proliferation"). Furthermore, endogenous proliferation is found closely associated with differentiation into memory phenotype cells, suggesting that different mechanism appears to be involved in endogenous proliferation. From preliminary studies we found that: 1) initial accumulation of T cells that undergo endogenous proliferation is found mainly in the spleen but not in the mesenteric lymph nodes; 2) depletion of gut flora by antibiotic treatment has little effect on endogenous proliferation; 3) endogenous proliferation of naive T cells is mainly controlled by the presence of memory T cells; 4) repertoire complexity but not total numbers of the memory T cells plays a key role in limiting the endogenous proliferation; 5) memory CD4 T cells suppress endogenous proliferation of both naive CD4 and CD8 T cells, while memory CD8 T cells only suppress endogenous proliferation of naive CD8 T cells; 6) memory T cells compete with each other, not only to maintain their pool size but also to maximize the repertoire complexity. We hypothesize that endogenous T cell proliferation, triggered by self-antigens expressed on DCs generates a diverse repertoire of memory T cells. These memory cells alter DC functions, further regulating subsequent naive T cell proliferation. Three specific aims are proposed in order to test the hypothesis. Aim #1 will determine if DCs are required for the induction of endogenous proliferation in lymphopenic hosts. Aim #2 will define cellular mechanisms mediating memory T cell inhibition of naive T cell endogenous proliferation. Aim #3 will define the contribution of apoptosis to memory cell homeostasis. The studies are clinically relevant to establish strategies to avoid dysregulated lymphocyte homeostasis, often found in autoimmunity or therapeutic immunoablation. PUBLIC HEALTH RELEVANCE: The immune system evolves an active process of homeostatic control mechanism that ensures its diversity and functionality. Homeostatic dysregulation is believed to link to the development of multiple disorders, including immunodeficiency, autoimmunity and a failure of solid organ transplantation. The current proposal aims to investigate underlying cellular mechanism, and the results will aid our understanding of the immune mechanism and facilitate therapeutic strategies to treat disorders caused by the dysregulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell function
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
Foxp3+ regulatory T cell-dependent treatment of allergic inflammation by glucocorticoids
海外基金